Skip to main content
Caplight Logo









Inside Therapeutics

Inside Therapeutics

Private
AngoulêmeHealthcare & Life Scienceshttps://insidetherapeutics.com/

Last Round

VC Round

Jun 3, 2025

Total Funding Raised

$1.39M

Company Overview

Inside Therapeutics is a biotechnology company that develops and markets instruments and services for the manufacturing of lipid nanoparticles for therapeutic RNA.

Sector

Healthcare & Life Sciences

Verticals

Biotech Equipment, Biotechnology, Drug Discovery, Medical Devices

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Non-AI

Keywords

LNP formulationlipid nanoparticle formulationnanoparticle synthesismicrofluidic platformRNA deliveryContract Research OrganizationCRORNA therapiesformulation servicesmRNA deliverylab-on-a-chipbiotech equipmentpreclinical developmentnanomedicinedrug development tools

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Inside Therapeutics Comparables

Compare Inside Therapeutics with similar companies based on industry and business-model similarity.

Inside Therapeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
PreciGenome
85%
enParticle
81%
MEPSGEN
81%

Inside Therapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundJun 3, 2025
SeedJun 20, 2024

Inside Therapeutics Investors

Notable investors and investment history

Inside Therapeutics investors
InvestorRounds
Aquiti GestionVC Round
Newfund NAEH InnopyVC Round
SkaleParkSeed, VC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 20, 2024

    $1.39M round led by newfundcap and SkalePark.

Inside Therapeutics Filings

Explore SEC and related filing metadata, where available.

Inside Therapeutics filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Inside Therapeutics's valuation, stock price, and market status.

Is Inside Therapeutics a public or private company?

Inside Therapeutics is a private company.

What is the current stock price of Inside Therapeutics?

Inside Therapeutics is a private company with no public stock price. No recent secondary market data is available.

How much is Inside Therapeutics worth (valuation)?

Valuation information for Inside Therapeutics is not publicly available.

Can I buy Inside Therapeutics stock?

Inside Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Inside Therapeutics's last funding round?

Funding round information for Inside Therapeutics is not publicly available.

Who are the main investors in Inside Therapeutics?

Investor information for Inside Therapeutics is not publicly disclosed.

Will Inside Therapeutics IPO soon?

No public IPO plans have been announced for Inside Therapeutics.

How can I track Inside Therapeutics secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Inside Therapeutics's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersAngoulême
Year Founded2022
Last FundingJun 3, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?